69 related articles for article (PubMed ID: 15853832)
1. Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours.
Costa-Guda J; Rosen ED; Jensen RT; Chung DC; Arnold A
Clin Endocrinol (Oxf); 2005 May; 62(5):603-6. PubMed ID: 15853832
[TBL] [Abstract][Full Text] [Related]
2. Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumours.
Lindberg D; Akerström G; Westin G
Clin Endocrinol (Oxf); 2007 Jan; 66(1):110-4. PubMed ID: 17201809
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
[TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP
Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the TSC1 gene in adenocarcinoma of the lung.
Takamochi K; Ogura T; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Suzuki K; Esumi H
Lung Cancer; 2004 Dec; 46(3):271-81. PubMed ID: 15541811
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
7. Lack of genetic and epigenetic changes in meningiomas without NF2 loss.
van Tilborg AA; Morolli B; Giphart-Gassler M; de Vries A; van Geenen DA; Lurkin I; Kros JM; Zwarthoff EC
J Pathol; 2006 Mar; 208(4):564-73. PubMed ID: 16353169
[TBL] [Abstract][Full Text] [Related]
8. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
[TBL] [Abstract][Full Text] [Related]
9. Molecular evidence for independent origin of multifocal neuroendocrine tumors of the enteropancreatic axis.
Katona TM; Jones TD; Wang M; Abdul-Karim FW; Cummings OW; Cheng L
Cancer Res; 2006 May; 66(9):4936-42. PubMed ID: 16651451
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
van Wezel T; Lombaerts M; van Roon EH; Philippo K; Baelde HJ; Szuhai K; Cornelisse CJ; Cleton-Jansen AM
Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
13. Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression.
Barghorn A; Komminoth P; Bachmann D; Rütimann K; Saremaslani P; Muletta-Feurer S; Perren A; Roth J; Heitz PU; Speel EJ
J Pathol; 2001 Aug; 194(4):451-8. PubMed ID: 11523053
[TBL] [Abstract][Full Text] [Related]
14. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
[TBL] [Abstract][Full Text] [Related]
16. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
[TBL] [Abstract][Full Text] [Related]
17. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.
Min Kim S; Sun CD; Park KC; Kim HG; Lee WJ; Choi SH
J Surg Oncol; 2006 Oct; 94(5):418-25. PubMed ID: 16967453
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
Xia JC; Weng DS; Li JT; Qin HD; Mai SJ; Feng BJ; Fan Q; Feng QS; Huang LX; Yu XJ; Pan ZZ; Li YQ; Wang QJ; Zhan YQ; Chen SP; He J; Huang WL; Wu PH; Zeng YX
Cancer Genet Cytogenet; 2006 Apr; 166(2):166-72. PubMed ID: 16631475
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]